Clinical Trial Update: Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating semaglutide for cognitive dysfunction in adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED